Stock Analiz

Healthequity, Inc. (HQY) financials: revenue, earnings and cash flow

Fiscal 2017–2026 + TTM · from SEC filings · data as of November 16, 2026

Summary

Healthequity’s revenue went from $178M in fiscal 2017 to $1.3B in fiscal 2026, growth of about 24.8% a year.

Net income in fiscal 2026 was $215M, a net margin of 16.4%; the highest of the period.

Over the twelve months to July 31, 2026, revenue was $1.4B and net income $236M.

Free cash flow was $455M in fiscal 2026 and positive in 10 of the 10 years shown.

The diluted share count rose 46% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2017: $178M172018: $230M182019: $287M192020: $532M202021: $734M212022: $757M222023: $862M232024: $1000M242025: $1.2B252026: $1.3B26$1.3B
Net income
2017: $26M172018: $47M182019: $74M192020: $40M202021: $9M212022: -$44M222023: -$26M232024: $56M242025: $97M252026: $215M26$215M
Free cash flow
2017: $42M172018: $76M182019: $110M192020: $98M202021: $169M212022: $132M222023: $147M232024: $241M242025: $338M252026: $455M26$455M
EPS (diluted)
2017: $0.44172018: $0.77182019: $1.17192020: $0.58202021: $0.12212022: $-0.53222023: $-0.31232024: $0.64242025: $1.09252026: $2.4626$2.46

Income statement

Fiscal yearTTM2026202520242023202220212020201920182017
Revenue$1.4B$1.3B$1.2B$1000M$862M$757M$734M$532M$287M$230M$178M
Gross profit$970M$913M$777M$623M$492M$425M$415M$326M$181M$135M$106M
Operating income$351M$322M$162M$118M$9M-$24M$34M$77M$78M$54M$41M
Net income$236M$215M$97M$56M-$26M-$44M$9M$40M$74M$47M$26M
EPS (diluted)$2.77$2.46$1.09$0.64$-0.31$-0.53$0.12$0.58$1.17$0.77$0.44
R&D$278M$263M$240M$219M$193M$157M$125M$78M$35M$27M$22M
Revenue growth—+9.5%+20.0%+16.0%+13.9%+3.1%+37.9%+85.2%+25.1%+28.7%+40.7%

Cash flow

Fiscal yearTTM2026202520242023202220212020201920182017
Operating cash flow$490M$457M$340M$243M$151M$141M$182M$105M$113M$82M$46M
Capital spending-$2M-$2M-$2M-$2M-$3M-$9M-$13M-$7M-$4M-$5M-$4M
Free cash flow$488M$455M$338M$241M$147M$132M$169M$98M$110M$76M$42M
Dividends paid——————————$0
Buybacks$404M$299M$121M$0$0——————
Stock-based pay$81M$73M$96M$77M$63M$53M$43M$40M$21M$14M$8M

Balance sheet

Fiscal yearTTM2026202520242023202220212020201920182017
Cash—$319M$296M$404M$254M$225M$329M$192M$361M$199M$140M
Debt—$1.0B$1.1B$933M$994M$1.0B$1.1B$1.3B$0——
Equity—$2.1B$2.1B$2.0B$1.9B$1.9B$1.4B$1.0B$477M$346M$262M
Total assets—$3.4B$3.4B$3.2B$3.1B$3.1B$2.7B$2.6B$510M$369M$279M
Shares (diluted)84M87M89M87M84M83M76M68M63M62M60M

Margins and returns

Fiscal yearTTM2026202520242023202220212020201920182017
Gross margin71.2%69.5%64.8%62.3%57.1%56.1%56.6%61.3%63.1%58.8%59.6%
Operating margin25.8%24.6%13.5%11.8%1.1%-3.2%4.6%14.5%27.0%23.7%23.1%
Net margin17.4%16.4%8.1%5.6%-3.0%-5.9%1.2%7.5%25.7%20.6%14.8%
FCF margin35.8%34.6%28.1%24.1%17.1%17.5%23.0%18.4%38.1%33.2%23.5%
ROIC—8.1%4.2%2.9%0.2%-0.6%1.1%3.0%15.9%14.3%10.3%
ROE—10.2%4.6%2.7%-1.4%-2.4%0.6%3.9%15.5%13.7%10.1%

Frequently asked questions

What is Healthequity’s annual revenue?

$1.3B in fiscal 2026 and $1.4B over the twelve months to July 31, 2026.

How much profit does Healthequity make?

Net income was $215M in fiscal 2026 (net margin 16.4%).

Is Healthequity’s revenue growing?

Yes: revenue rose 9.5% in fiscal 2026 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.